govt.fyi
Back to HB 4783
Texas Legislature· HB 4783Effective on 9/1/25

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses, the official text

Shown verbatim: the complete text as captured from the official page posted by the Texas Legislature, fetched 2026-08-29. Where this bill amends existing law, language marked for deletion in the official page appears here in brackets. This is the enrolled version. The official bill page.
H.B. No. 4783

AN ACT

relating to a report on governmental opioid antagonist programs to

reverse and prevent opioid overdoses.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Subchapter B, Chapter 461A, Health and Safety

Code, is amended by adding Section 461A.060 to read as follows:

Sec. 461A.060. BIENNIAL REPORT ON OPIOID ANTAGONIST

PROGRAMS FOR OPIOID OVERDOSE REVERSAL AND PREVENTION. (a) In this

section, "opioid antagonist" has the meaning assigned by Section

483.101.

(b) Not later than October 1 of each even-numbered year, the

commission shall:

(1) prepare a report evaluating the distribution of

opioid antagonists in this state to reverse and prevent opioid

overdoses; and

(2) submit the report to the governor, the lieutenant

governor, and the speaker of the house of representatives.

(c) The report described by Subsection (b) must:

(1) include a needs assessment for the opioid

antagonist programs established by state agencies and institutions

of higher education;

(2) establish a statewide saturation goal for opioid

antagonists and include:

(A) a description of the data sources and

methodology used to estimate insufficiencies in the current supply

of opioid antagonists; and

(B) a communications plan to address opioid

overdoses in areas of this state at higher risk for increased

numbers of overdoses;

(3) include a description of all state and federal

money appropriated to governmental opioid antagonist programs;

(4) establish opioid antagonist distribution

strategies for this state;

(5) list and describe all available state and

federally funded purchase and distribution programs for opioid

antagonists; and

(6) recommend improvements for addressing opioid

overdoses among high-risk populations, including school-aged

children, pregnant and postpartum women, and individuals residing

in rural areas of this state.

(d) In preparing the report under this section, the

commission shall coordinate and consult with each state agency and

institution of higher education that receives funding or other

resources for the distribution of opioid antagonists.

SECTION 2. This Act takes effect September 1, 2025.

______________________________
______________________________

President of the Senate
Speaker of the House

I certify that H.B. No. 4783 was passed by the House on May 6,

2025, by the following vote: Yeas 137, Nays 10, 1 present, not

voting; and that the House concurred in Senate amendments to H.B.

No. 4783 on May 23, 2025, by the following vote: Yeas 112, Nays 24,

1 present, not voting.

______________________________

Chief Clerk of the House

I certify that H.B. No. 4783 was passed by the Senate, with

amendments, on May 20, 2025, by the following vote: Yeas 30, Nays

1.

______________________________

Secretary of the Senate

APPROVED: __________________

Date

__________________

Governor
Every fact on this page links to its source, starting with the official bill record.